Minnesota Regional Sleep Disorders Center and Departments of Psychiatry, Hennepin County Medical Center and University of Minnesota Medical School, Minneapolis, MN, USA.
Sleep Breath. 2022 Sep;26(3):1289-1298. doi: 10.1007/s11325-022-02574-6. Epub 2022 Mar 3.
To review how REM sleep behavior disorder (RBD) is a complex condition with heterogeneous underlying disorders; and to review clinical management issues and prognostic implications.
PubMed literature search and contents from the first textbook of RBD (2018).
RBD, with its core objective diagnostic feature of REM-without-atonia (RWA) documented by video-polysomnography, can emerge during the entire lifespan, and can initially present as an idiopathic (isolated) condition (iRBD), or can be associated with a broad spectrum of disorders including narcolepsy, alpha-synuclein neurodegenerative disorders (esp. Parkinson's disease [PD] and dementia with Lewy bodies [DLB]), paraneoplastic neurological syndromes and autoimmune disorders, CNS lesions (e.g., tumors, stroke), other neurological disorders, psychiatric disorders (PTSD, mood disorders), can be triggered by antidepressant/other medications, and can emerge acutely with drug withdrawal states, toxic-metabolic states, etc. Important clinical issues include the evolution of iRBD to PD/DLB in most middle-aged and older patients over a period of years to several decades, with compelling prognostic implications, along with the hope of enrolling these patients in future clinical trials to test promising disease-modifying therapies. Also, the strong link of RBD with narcolepsy needs further investigation. Parasomnia overlap disorder involves RBD and NREM parasomnias that can be idiopathic or linked with a broad range of clinical disorders. RBD usually responds to therapy consisting mainly of melatonin and/or clonazepam at bedtime. The complex associations of RBD with OSA are being increasingly investigated. RBD mimics with dream-enactment need to be recognized for diagnostic and management purposes, including severe OSA, NREM parasomnias, PLMD, nocturnal seizures, and other conditions.
The clinical and research RBD fields span across the disciplines of neurology, pulmonary, psychiatry, psychology, and pediatric sleep medicine, along with physical medicine and rehabilitation medicine, other allied disciplines, and the basic and clinical neurosciences.
回顾 REM 睡眠行为障碍(RBD)是一种具有异质性潜在疾病的复杂病症;并回顾临床管理问题和预后意义。
通过 PubMed 文献检索和 RBD 的第一本教科书(2018 年)的内容进行综述。
RBD 以视频多导睡眠图记录的 REM 无动性(RWA)为核心诊断特征,可在整个生命周期中出现,最初可表现为特发性(孤立性)疾病(iRBD),也可与广泛的疾病相关联,包括发作性睡病、α-突触核蛋白神经退行性疾病(特别是帕金森病 [PD] 和路易体痴呆 [DLB])、副肿瘤性神经系统综合征和自身免疫性疾病、中枢神经系统病变(如肿瘤、中风)、其他神经疾病、精神疾病(创伤后应激障碍、情绪障碍),可由抗抑郁药/其他药物诱发,也可在药物戒断状态、毒代谢状态等急性情况下出现。重要的临床问题包括 iRBD 在大多数中年和老年患者中在数年内到数十年内发展为 PD/DLB,具有令人信服的预后意义,同时希望将这些患者纳入未来的临床试验中,以测试有前途的疾病修饰治疗。此外,RBD 与发作性睡病的强烈关联需要进一步研究。异态睡眠重叠障碍涉及 RBD 和非快速动眼期(NREM)异态睡眠,可特发性或与广泛的临床疾病相关。RBD 通常对主要由褪黑素和/或氯硝西泮组成的睡前治疗有反应。RBD 与阻塞性睡眠呼吸暂停(OSA)的复杂关联正在得到越来越多的研究。出于诊断和管理目的,需要识别 RBD 模仿梦境表现,包括严重的 OSA、NREM 异态睡眠、周期性肢体运动障碍、夜间发作和其他情况。
临床和研究 RBD 领域跨越神经病学、肺病学、精神病学、心理学和儿科睡眠医学以及物理医学和康复医学、其他相关学科以及基础和临床神经科学等学科。